KR100408017B1 - 종양괴사인자와 인터루킨-4의 융합단백질 - Google Patents
종양괴사인자와 인터루킨-4의 융합단백질 Download PDFInfo
- Publication number
- KR100408017B1 KR100408017B1 KR10-2000-0067843A KR20000067843A KR100408017B1 KR 100408017 B1 KR100408017 B1 KR 100408017B1 KR 20000067843 A KR20000067843 A KR 20000067843A KR 100408017 B1 KR100408017 B1 KR 100408017B1
- Authority
- KR
- South Korea
- Prior art keywords
- tnf
- cells
- tumor
- fusion protein
- metha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
- 인터루킨-4(IL-4)를 세포막에 결합된 형태로 발현시키기 위한, 막 결합기능을 나타내는 종양괴사인자(TNF)의 세포질내 도메인, 막투과 도메인 및 세포질외 도메인을 암호화하는 염기서열과 IL-4를 암호화하는 염기서열을 포함하고, 서열번호 8로 나타내어지는, TNF와 IL-4의 융합단백질(IL-4/TNF)을 암호화하는 염기서열.
- 제 1항의 염기서열로 부터 번역되는 서열번호 9로 나타내어지는 종양괴사인자와 인터루킨-4의 융합단백질(IL-4/TNF)의 아미노산 서열.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0067843A KR100408017B1 (ko) | 2000-11-15 | 2000-11-15 | 종양괴사인자와 인터루킨-4의 융합단백질 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0067843A KR100408017B1 (ko) | 2000-11-15 | 2000-11-15 | 종양괴사인자와 인터루킨-4의 융합단백질 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020037899A KR20020037899A (ko) | 2002-05-23 |
KR100408017B1 true KR100408017B1 (ko) | 2003-12-06 |
Family
ID=19699190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0067843A KR100408017B1 (ko) | 2000-11-15 | 2000-11-15 | 종양괴사인자와 인터루킨-4의 융합단백질 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100408017B1 (ko) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993019777A1 (en) * | 1992-03-30 | 1993-10-14 | Immunex Corporation | Fusion proteins comprising tumor necrosis factor receptor |
WO1995012675A1 (en) * | 1993-11-04 | 1995-05-11 | Cytoclonal Pharmaceutics, Inc. | A fusion protein and method for making and using same |
-
2000
- 2000-11-15 KR KR10-2000-0067843A patent/KR100408017B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993019777A1 (en) * | 1992-03-30 | 1993-10-14 | Immunex Corporation | Fusion proteins comprising tumor necrosis factor receptor |
WO1995012675A1 (en) * | 1993-11-04 | 1995-05-11 | Cytoclonal Pharmaceutics, Inc. | A fusion protein and method for making and using same |
Non-Patent Citations (4)
Title |
---|
Cytokine, Vol.8, pp900-909 (1996.12.) * |
논문(서열번호 8번 염기서열에 대한 BLAST 검색결과, 1993.9.12) * |
논문(서열번호 9번 아미노산 서열에 대한 BLAST 검색결과, 1998.7.15) * |
논문(항암시의 부작용을 경감시키기 위한 사이토카인의 농도조절을 위해 IL-4/TNF 융합단백질을 제조하여 TNF의 막투과 도메인의 성질을 이용한 단백질, Gene Ther 2000 May;7(10):837-43) * |
Also Published As
Publication number | Publication date |
---|---|
KR20020037899A (ko) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220002401A1 (en) | Chimeric antigen receptor and its use | |
KR102226917B1 (ko) | 신규 유전자 변형 자연살해 세포주 및 그의 용도 | |
Liu et al. | The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. | |
Dubois et al. | Preassociation of IL-15 with IL-15Rα-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action | |
JP2023116674A (ja) | Car発現ベクター及びcar発現t細胞 | |
EP3039040B1 (en) | Anti cd30 chimeric antigen receptor and its use | |
WO2017201432A2 (en) | Tethered interleukin-2 to its receptor il-2rbeta, a platform to enhance natural killer and regulatory t cell activity | |
TWI830771B (zh) | 包含核酸及car修飾的免疫細胞的治療劑及其應用 | |
CN108250303B (zh) | 单域抗体融合蛋白及其应用 | |
CA2979835A1 (en) | Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto | |
CN110872577A (zh) | 修饰的免疫细胞及其应用 | |
KR102333377B1 (ko) | 키메라 항원 수용체 | |
US11959084B2 (en) | Nucleic acid construct | |
WO2018056736A1 (ko) | 신규 자연살해 세포주 및 그의 용도 | |
EP3768305B1 (en) | Modified oncolytic adenoviruses | |
JPWO2020223537A5 (ko) | ||
EP3759144A1 (en) | Fusion protein constructs comprising an anti-muc1 antibody and il-15 | |
US20210395320A1 (en) | Protein heterodimer and use thereof | |
EP4041758A1 (en) | An oncolytic virus vector coding for variant interleukin-2 (vil-2) polypeptide | |
JP2023524873A (ja) | 方法 | |
KR100408017B1 (ko) | 종양괴사인자와 인터루킨-4의 융합단백질 | |
CN114302957A (zh) | 具有能够表达由癌细胞靶向区与hvem胞外结构域形成的融合蛋白的表达盒的重组单纯疱疹病毒和其用途 | |
JP2003500342A (ja) | 哺乳動物の抗腫瘍治療または抗ウイルス治療用に設計された組成物 | |
US20210107966A1 (en) | Natural killer cell products and methods | |
WO2024097637A1 (en) | Hla-a3-restricted t cell receptors against braf with v600e mutation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121102 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20131031 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20151125 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20161123 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20171222 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20191017 Year of fee payment: 17 |